Evidence map›Paper›PMID 36690429›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2023

A roadmap to ALS prevention: strategies and priorities.

Michael Benatar, Stephen A Goutman, Kim A Staats, Eva L Feldman, Marc Weisskopf, Evelyn Talbott, Kuldip D Dave, Neil M Thakur, Ammar Al-Chalabi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael BenatarDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA MBenatar@med.miami.edu.ORCID 0000-0003-4241-5135
Stephen A GoutmanNeurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-8780-6637
Kim A StaatsStaats Life Sciences Consulting, Los Angeles, California, USA.ORCID 0000-0001-8392-7992
Eva L FeldmanNeurology, University of Michigan, Ann Arbor, Michigan, USA.
Marc WeisskopfDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0003-4513-9834
Evelyn TalbottDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
Kuldip D DaveALS Association, Washington, District of Columbia, USA.
Neil M ThakurALS Association, Washington, District of Columbia, USA.
Ammar Al-ChalabiDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.ORCID 0000-0002-4924-7712

Funding

Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial; Administrative SupplementR01NS105479 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BENATAR, MICHAEL, WUU, JOANNE · 2018 to 2022
$3.0M
Medical Research Council MR/R024804/1Motor Neurone Disease Association AL-CHALABI/APR15/844-791Motor Neurone Disease Association ALCHALABI-DOBSON/APR14/829-791Motor Neurone Disease Association ALCHALABI-TALBOT/APR14/926-794NINDS NIH HHS R01 NS105479
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyotrophic Lateral SclerosisHumansALS

Identifiers

PMID36690429
PMCPMC10176353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.